Philip M.W. Bath mostly deals with Stroke, Internal medicine, Surgery, Anesthesia and Randomized controlled trial. The concepts of his Stroke study are interwoven with issues in Physical therapy, Vascular disease, Blood pressure and Clinical trial. He interconnects Endocrinology and Cardiology in the investigation of issues within Internal medicine.
His Surgery research includes themes of Systematic review, Hyperintensity and Telmisartan. His Anesthesia study combines topics in areas such as Granulocyte colony-stimulating factor, Brain ischemia, Ischemia, Nitric oxide and Aspirin. The Randomized controlled trial study combines topics in areas such as Psychiatry, Intracerebral hemorrhage, Tinzaparin sodium and Intensive care medicine.
His primary areas of study are Stroke, Internal medicine, Cardiology, Randomized controlled trial and Blood pressure. His Stroke study integrates concerns from other disciplines, such as Anesthesia, Physical therapy, Clinical trial and Surgery. He regularly ties together related areas like Endocrinology in his Internal medicine studies.
His Cardiology research incorporates elements of Candesartan, Platelet, Ischaemic stroke and Ischemic stroke. His studies deal with areas such as Adverse effect and Intracerebral hemorrhage as well as Randomized controlled trial. His work carried out in the field of Blood pressure brings together such families of science as Hemodynamics, Cerebral blood flow, Nitric oxide and Thrombolysis.
The scientist’s investigation covers issues in Stroke, Internal medicine, Cardiology, Randomized controlled trial and Anesthesia. Philip M.W. Bath studies Modified Rankin Scale which is a part of Stroke. His Lacunar stroke, Clopidogrel, Cilostazol and Case fatality rate study in the realm of Internal medicine connects with subjects such as In patient.
His Cardiology study incorporates themes from Acute ischemic stroke, Ischemic stroke, Ischaemic stroke, Disease and Acute stroke. Philip M.W. Bath works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Platelet transfusion and, in certain cases, Anticoagulant. His Anesthesia research is multidisciplinary, incorporating elements of Intracerebral hemorrhage, Incidence, Stimulation, Transdermal glyceryl trinitrate and Neurology.
Philip M.W. Bath spends much of his time researching Stroke, Randomized controlled trial, Internal medicine, Cardiology and Anesthesia. His Stroke research includes elements of Adverse effect, Confidence interval, Meta-analysis, Emergency medicine and Dysphagia. His research in Randomized controlled trial intersects with topics in Odds ratio, Thrombolysis, Clinical trial and Modified Rankin Scale.
His biological study deals with issues like Lacunar stroke, which deal with fields such as Disease. He combines subjects such as Stimulation, Pharynx and Blood pressure with his study of Anesthesia. Philip M.W. Bath focuses mostly in the field of Aspirin, narrowing it down to matters related to Dipyridamole and, in some cases, Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
Peter A. Ringleb;Marie Germaine Bousser;Gary Ford;Philip Bath.
Cerebrovascular Diseases (2008)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco;Hans-Christoph Diener;Salim Yusuf;Daniel Cotton.
The New England Journal of Medicine (2008)
Platelet size: measurement, physiology and vascular disease
P. M. W. Bath;R. J. Butterworth.
Blood Coagulation & Fibrinolysis (1996)
Blood Pressure and Clinical Outcomes in the International Stroke Trial
Jo Leonardi-Bee;Philip M.W. Bath;Stephen J. Phillips;Peter A.G. Sandercock.
Telmisartan to prevent recurrent stroke and cardiovascular events.
Salim Yusuf;Salim Yusuf;Hans-Christoph Diener;Ralph L. Sacco;Daniel Cotton.
The New England Journal of Medicine (2008)
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events A Systematic Review
Parveen Rashid;Jo Leonardi-Bee;Philip Bath.
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
J O'Brien;H Duncan;G Kirsh;V Allen.
The Lancet (2000)
High Blood Pressure in Acute Stroke and Subsequent Outcome. A Systematic Review
Mark Willmot;Jo Leonardi-Bee;Philip M.W. Bath.
Influence of platelet size on outcome after myocardial infarction
J. F. Martin;P. Bath;Michael Leslie Burr.
The Lancet (1991)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Else Charlotte Sandset;Else Charlotte Sandset;Philip M. W. Bath;Gudrun Boysen;Dalius Jatuzis.
The Lancet (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: